EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility

Yesha Patel iD, Vijay Soni iD, Kyu Y Rhee iD, John D Helmann iD

mBio · 2023

DOI: 10.1128/mbio.03168-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Yesha Patel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Cornell University, Ithaca, New York, USA. Hauptthemen laut MEDLINE: Rifampin, Mycobacterium tuberculosis. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rifampicin (RIF) is one of the most valued drugs in the treatment of tuberculosis. TB treatment relies on a combination therapy and for multidrug-resistant strains may include β-lactams.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinMycobacterium tuberculosisPeptidoglycanbeta-LactamsCefuroximeAcetylglucosamineDrug Resistance, BacterialMutationUridine DiphosphateDNA-Directed RNA PolymerasesBacterial ProteinsMicrobial Sensitivity TestsAntitubercular Agents

Stichwörter der Autor:innen

Bacillus subtilisMycobacterium tuberculosisRNA polymerasesantibiotic resistanceantibiotic synergymetabolomicspeptidoglycanrifampicinβ-lactams

Substanzen

RifampinPeptidoglycanbeta-LactamsCefuroximeAcetylglucosamineUridine DiphosphateDNA-Directed RNA PolymerasesBacterial ProteinsAntitubercular Agents

Autor:innen und Institutionen

  • Department of Microbiology, Cornell University, Ithaca, New York, USA.
  • Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.

ORCID-Profile: Yesha Patel, Vijay Soni, Kyu Y Rhee, John D Helmann

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • HHS | National Institutes of Health

Zitieren

APA

Patel, Y., Soni, V., Rhee, K. Y., & Helmann, J. D. (2023). Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility. mBio. https://doi.org/10.1128/mbio.03168-22

Vancouver

Patel Y, Soni V, Rhee KY, Helmann JD. Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility. mBio. 2023. doi:10.1128/mbio.03168-22

BibTeX
@article{Patel2023,
  author = {Patel, Yesha and Soni, Vijay and Rhee, Kyu Y and Helmann, John D},
  title = {Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility},
  journal = {mBio},
  year = {2023},
  doi = {10.1128/mbio.03168-22}
}
Kostenlos starten →